Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v2.4.0.8
Stockholders' Equity
9 Months Ended
Mar. 31, 2014
Stockholders Equity Note [Abstract]  
Stockholders Equity Note Disclosure [Text Block]
8.
Stockholders’ Equity
 
Preferred Stock
The Company’s Board of Directors is authorized to issue, at any time, without further stockholder approval, up to 1 million shares of preferred stock. The Board of Directors has the authority to fix and determine the voting rights, rights of redemption and other rights and preferences of preferred stock. As of March 31, 2014, there were no shares of preferred stock issued and outstanding.
 
Common Stock 
As of June 30, 2013, the Company was authorized to issue up to 100 million shares of common stock.   On December 18, 2013, the Company amended its certificate of incorporation and increased the number of authorized shares of common stock to 175 million.   As of March 31, 2014, the Company had reserved up to 15 million shares of common stock for incentive compensation (stock options and restricted stock) and approximately 12.6 million shares of common stock for the exercise of warrants.
 
Issuances of common stock were as follows:
 
Warrant Exercise Inducement
On October 15, 2013, the Company announced that it was providing holders of its warrants issued as part of the January 2012 equity offering (the “January 2012 Warrants”) the opportunity to exercise at a reduced price for a limited period of time. The original exercise price of $ 0.88 was reduced to $0.40 until 5:00 p.m. on November 12, 2013 (the “Expiration Time”), after which the exercise price reverted back to $ 0.88 until these January 2012 Warrants expired on January 14, 2014. In October 2013, pursuant to this warrant exercise inducement, the Company issued 7.75 million shares of common stock and received exercise proceeds of approximately $ 3.1 million, net of expenses.
 
Private Placement Offering
In November 2013, the Company completed a private placement offering of 1.2 million shares of its common stock at a price of $0.40 per share, resulting in net proceeds of approximately $0.5 million.   The shares were issued in January 2014.
 
Warrants
The Company has historically financed its operations through the sale of common stock and warrants, sold together as units.
 
The following table summarizes all warrant activity for the nine months ended March 31, 2014:
 
 
 
Warrants
 
Weighted-
average
Exercise
Price
 
Outstanding as of June 30, 2013
 
 
25,395,940
 
$
1.23
 
Exercised
 
 
(7,750,000)
 
$
0.40
 
Expired
 
 
(8,876,029)
 
$
1.38
 
Outstanding as of March 31, 2014
 
 
8,769,911
 
$
1.38
 
 
 
 
 
 
 
 
 
Exercisable as of March 31, 2014
 
 
8,769,911
 
$
1.38